Back
Lantern Pharma 10K Form
Buy
66
LTRN
Lantern Pharma
Last Price:
6.13
Seasonality Move:
0.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-10 | 10K | LTRN/Lantern Pharma Annual |
| 2020-10-29 | 10Q | LTRN/Lantern Pharma Quarterly |
| 2020-07-30 | 10Q | LTRN/Lantern Pharma Quarterly |
Receive LTRN News And Ratings
See the #1 stock for the next 7 days that we like better than LTRN
LTRN Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-3.07M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.32 |
| Price / Book: | 1.81 |
Profitability
| EPS (TTM): | -1.63000 |
|---|---|
| Net Income (TTM): | $-17.53M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Lantern Pharma Earnings Forecast
Key Lantern Pharma Financial Ratios
- Per Share Earnings over the last 6 years have been positive in 1 years.
Lantern Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LTRN |
| Website: | lanternpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LTRN Technical Analysis vs Fundamental Analysis
Buy
66
Lantern Pharma (LTRN)
is a Buy
Is Lantern Pharma a Buy or a Sell?
-
Lantern Pharma stock is rated a Buy
The current Lantern Pharma [LTRN] share price is $6.03. The Score for LTRN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.